tiprankstipranks
Anika Therapeutics (ANIK)
NASDAQ:ANIK

Anika Therapeutics (ANIK) Income Statement

154 Followers

Anika Therapeutics Income Statement

Last quarter (Q4 2023), Anika Therapeutics's total revenue was $42.97M, an increase of 8.45% from the same quarter last year. In Q4, Anika Therapeutics's net income was $-63.00M. See Anika Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 166.66M$ 166.66M$ 156.24M$ 147.79M$ 130.46M$ 114.61M
Cost of Revenue
$ 33.41M$ 63.57M$ 62.66M$ -64.85M$ 61.43M$ 28.75M
Gross Profit
$ 103.09M$ 103.09M$ 93.58M$ 82.94M$ 69.03M$ 85.86M
Operating Expense
$ 57.74M$ 128.54M$ 112.98M$ 101.42M$ 83.49M$ 51.62M
Operating Income
$ 13.31M$ -87.64M$ -19.40M$ -18.48M$ -14.47M$ 34.25M
Net Non Operating Interest Income Expense
$ 2.31M$ 2.31M$ 654.00K$ -188.00K$ -302.00K$ 1.87M
Other Income Expense
$ -346.00K$ -318.00K$ -180.00K$ -21.09M$ -13.85M-
Pretax Income
$ -85.33M$ -85.33M$ -18.75M$ 2.43M$ -28.62M$ 36.12M
Tax Provision
$ 668.00K$ -2.66M$ -3.89M$ -1.71M$ -4.64M$ 8.93M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 14.96M$ -82.67M$ -14.86M$ 4.13M$ -23.98M$ 27.19M
Basic EPS
$ -5.65$ -5.64$ -1.02$ 0.29$ -1.69$ 1.93
Diluted EPS
$ -5.65$ -5.64$ -1.02$ 0.28$ -1.69$ 1.89
Basic Average Shares
$ 58.62M$ 14.66M$ 14.56M$ 14.40M$ 14.22M$ 14.12M
Diluted Average Shares
$ 58.62M$ 14.66M$ 14.56M$ 14.63M$ 14.22M$ 14.37M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
----$ 0.71$ 2.05
Rent Expense Supplemental
------
Total Expenses
$ 91.16M$ 192.11M$ 175.64M$ 36.57M$ 144.93M$ 80.36M
Net Income From Continuing And Discontinued Operation
$ -82.67M$ -82.67M$ -14.86M$ 4.13M$ -23.98M$ 27.19M
Normalized Income
$ -10.90M---$ -12.37M$ 27.19M
Interest Expense
------
EBIT
$ -23.71M$ -25.45M$ -18.73M$ 2.41M$ -14.47M$ 34.25M
EBITDA
$ -7.86M$ -11.23M$ -2.40M$ 24.90M$ -1.00M$ 40.24M
Currency in USD

Anika Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis